Knee Osteoarthritis
Conditions
Brief summary
Evaluate the effect of TECAR therapy combined with traditional physiotherapy on pain, balance, and quality of life in elderly men with knee osteoarthritis .
Detailed description
Eighty elderly men diagnosed with knee osteoarthritis will be recruited from physical therapy and orthopedic outpatient clinics. Following a baseline screening, patients will be randomly assigned into two parallel groups: The Study Group: Will include 40 men participating in true TECAR therapy plus a standardized traditional physiotherapy program for 8 weeks. The Control Group: Will include 40 men participating in sham TECAR therapy plus the same traditional physiotherapy program for 8 weeks.
Interventions
20 minutes per session (10 mins capacitive mode, 10 mins resistive mode), 3 sessions per week for 8 weeks will be applied around the affected knee joint. Thermal delivery will be adjusted to a comfortable, non-painful warm sensation
The device will be applied using identical electrode placement, application time, and interface screen indicators, but with the power output disabled so that no current or deep thermal energy is transferred to the tissues.
Standardized knee osteoarthritis rehabilitation including progressive quad/hamstring strengthening, hip abductor strengthening, range of motion exercises, and flexibility training
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical and radiographic diagnosis of mild and moderate bilateral or unilateral knee osteoarthritis meeting the American College of Rheumatology (ACR) criteria. * Presence of chronic knee pain lasting for more than 6 months. * Ability to ambulate independently with or without an assistive device.
Exclusion criteria
* Severe knee osteoarthritis (grade IV) requiring imminent surgical joint replacement. * History of previous knee arthroplasty, internal fixation, or significant trauma to the affected lower extremity. * Presence of pacemakers, metallic implants in the knee region, or severe. - peripheral vascular disease (absolute contraindications for TECAR therapy). * Intra-articular injections (corticosteroids, platelet-rich plasma, or hyaluronic acid) into the knee within the past 3 months. * Cognitive impairment or systemic inflammatory conditions (e.g., rheumatoid arthritis).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Intensity | Baseline and after 8 weeks | Visual Analog Scale will be used to assess pain intensity |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Balance | Baseline and after 8 weeks | Berg Balance Scale will be used to assess balance |
| Health-Related Quality of Life | Baseline and after 8 weeks | Short Form-12 Health Survey (SF-12) will be used to assess quality of life |